Heron Therapeutics | HRTX - Capital Social e Reservas





Capital Social e Reservas Alterar Data
ALKERMES USD 1.75B 67.76M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amarin USD 449.41M 9.87M 2026-03
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 568.42M 102.37M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Surmodics USD 111.31M 7.59M 2025-06
Ultragenyx Pharmaceutical USD -80M 89.16M 2025-12
Veracyte USD 1.31B 51.91M 2025-12
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03